High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$114K
$114,341
Total Sells (Filtered)
$0
$0
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
ACRV
P
Acrivon Therapeutics, Inc.
Levy Adam D.
• CFO
Discretionary BuyΔOwn +72.7%
2026-01-14
$14,999
|
||||||
| ACRV |
Acrivon Therapeutics, Inc.
|
CFO
Discretionary BuyΔOwn +72.7%
|
2026-01-14 | $14,999 | P | Form 4 |
| ACRV |
Acrivon Therapeutics, Inc.
|
CEO
Discretionary Buy
|
2026-01-14 | $82,124 | P | Form 4 |
| ACRV |
Acrivon Therapeutics, Inc.
|
COO
Discretionary BuyΔOwn +15.3%
|
2026-01-13 | $17,218 | P | Form 4 |